Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
Identifieur interne : 000C04 ( Ncbi/Merge ); précédent : 000C03; suivant : 000C05Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
Auteurs : Amy N. Hill [États-Unis] ; Joseph Jankovic [États-Unis] ; Kevin D A T. Vuong ; Don DonovanSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2003.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Collagen (therapeutic use), Drug Administration Schedule, Female, Humans, Male, Parkinsonian Disorders (complications), Parkinsonian Disorders (physiopathology), Patient Satisfaction, Questionnaires, Time Factors, Treatment Outcome, Vocal Cords (drug effects), Voice Disorders (drug therapy), Voice Disorders (etiology), Voice Disorders (physiopathology), Voice Quality.
- MESH :
- chemical , therapeutic use : Collagen.
- complications : Parkinsonian Disorders.
- drug effects : Vocal Cords.
- drug therapy : Voice Disorders.
- etiology : Voice Disorders.
- physiopathology : Parkinsonian Disorders, Voice Disorders.
- Aged, Aged, 80 and over, Drug Administration Schedule, Female, Humans, Male, Patient Satisfaction, Questionnaires, Time Factors, Treatment Outcome, Voice Quality.
Abstract
We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 +/- 8.6 years) completed the questionnaire after an average of 3.0 +/- 1.7 collagen injections, with an average of 13.8 +/- 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 +/- 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia.
DOI: 10.1002/mds.10554
PubMed: 14534926
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003660
- to stream PubMed, to step Curation: 003660
- to stream PubMed, to step Checkpoint: 003601
Links to Exploration step
pubmed:14534926Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.</title><author><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N" last="Hill">Amy N. Hill</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea><wicri:noRegion>Texas 77030</wicri:noRegion></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author><author><name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D A T" last="Vuong">Kevin D A T. Vuong</name></author><author><name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:14534926</idno><idno type="pmid">14534926</idno><idno type="doi">10.1002/mds.10554</idno><idno type="wicri:Area/PubMed/Corpus">003660</idno><idno type="wicri:Area/PubMed/Curation">003660</idno><idno type="wicri:Area/PubMed/Checkpoint">003601</idno><idno type="wicri:Area/Ncbi/Merge">000C04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.</title><author><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N" last="Hill">Amy N. Hill</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea><wicri:noRegion>Texas 77030</wicri:noRegion></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author><author><name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D A T" last="Vuong">Kevin D A T. Vuong</name></author><author><name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Collagen (therapeutic use)</term><term>Drug Administration Schedule</term><term>Female</term><term>Humans</term><term>Male</term><term>Parkinsonian Disorders (complications)</term><term>Parkinsonian Disorders (physiopathology)</term><term>Patient Satisfaction</term><term>Questionnaires</term><term>Time Factors</term><term>Treatment Outcome</term><term>Vocal Cords (drug effects)</term><term>Voice Disorders (drug therapy)</term><term>Voice Disorders (etiology)</term><term>Voice Disorders (physiopathology)</term><term>Voice Quality</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Collagen</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Vocal Cords</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Voice Disorders</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Voice Disorders</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinsonian Disorders</term><term>Voice Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Drug Administration Schedule</term><term>Female</term><term>Humans</term><term>Male</term><term>Patient Satisfaction</term><term>Questionnaires</term><term>Time Factors</term><term>Treatment Outcome</term><term>Voice Quality</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 +/- 8.6 years) completed the questionnaire after an average of 3.0 +/- 1.7 collagen injections, with an average of 13.8 +/- 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 +/- 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">14534926</PMID><DateCreated><Year>2003</Year><Month>10</Month><Day>09</Day></DateCreated><DateCompleted><Year>2004</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.</ArticleTitle><Pagination><MedlinePgn>1190-2</MedlinePgn></Pagination><Abstract><AbstractText>We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 +/- 8.6 years) completed the questionnaire after an average of 3.0 +/- 1.7 collagen injections, with an average of 13.8 +/- 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 +/- 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia.</AbstractText><CopyrightInformation>Copyright 2003 Movement Disorder Society</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Amy N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankovic</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Vuong</LastName><ForeName>Kevin D A T</ForeName><Initials>KD</Initials></Author><Author ValidYN="Y"><LastName>Donovan</LastName><ForeName>Don</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-34-5</RegistryNumber><NameOfSubstance UI="D003094">Collagen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003094">Collagen</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D020734">Parkinsonian Disorders</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D017060">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014827">Vocal Cords</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014832">Voice Disorders</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014833">Voice Quality</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14534926</ArticleId><ArticleId IdType="doi">10.1002/mds.10554</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><noCountry><name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name><name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D A T" last="Vuong">Kevin D A T. Vuong</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N" last="Hill">Amy N. Hill</name></noRegion><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000C04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:14534926
|texte= Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:14534926" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |